Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves

Research in Veterinary Science

Volumn 82, Issue 3, 2007, Pages 398-404

  Ismail, M ^a   El Kattan, Y A ^b  

^a Cairo University   (Egypt)

^b ANIMAL HEALTH RESEARCH INSTITUTE   (Egypt)

Author keywords

Bioavailability; Calves; Fluoroquinolones; HPLC; Mannheimia haemolytica; Marbofloxacin; Minimum inhibitory concentration; Pharmacodynamics; Pharmacokinetics; Protein binding

Indexed keywords

MARBOFLOXACIN; OFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BACTERIUM ISOLATE; CALF (BOVINE); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; GRAM NEGATIVE INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MANNHEIMIA HAEMOLYTICA; MEAN RESIDENCE TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PROTEIN BINDING; SINGLE DRUG DOSE; ULTRAVIOLET RADIATION;

ANIMALS; AREA UNDER CURVE; CASE-CONTROL STUDIES; CATTLE; ENZYME INHIBITORS; FLUOROQUINOLONES; HEALTH; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; PASTEURELLACEAE INFECTIONS; QUINOLONES;

MANNHEIMIA HAEMOLYTICA;

EID: 34147191129     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2006.10.001     Document Type: Article

References (44)

1. Albarellos G.A., Montoya L., and Landoni M.F. Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administrations to cats. Veterinary Journal 170 (2005) 222-229
2. Aliabadi F.S., and Lees P. Pharmacokinetics and pharmacodynamic integration of marbofloxacin in calf serum, exudates and transudate. Journal of Veterinary Pharmacology and Therapeutics 25 (2002) 161-174
3. Aliabadi F.S., and Lees P. Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Research in Veterinary Science 74 (2003) 247-259
4. Ames T.R., Larson L.V., and Stowf C.M. Oxytetracycline concentrations in healthy and diseased calves. American Journal of Veterinary Research 44 (1983) 1354-1357
5. Apley M.D., and Upson D.W. Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia. American Journal of Veterinary Research 54 (1993) 937-942
6. Baggot J.D. Some aspects of clinical pharmacokinetics in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 1 (1978) 5-18
7. Baggot J.D. Distribution of antimicrobial agents in normal and diseased animals. Journal of the American Veterinary Medical Association 176 (1980) 1085-1090
8. Bousquet-Melou A., Bernard S., Schneider M., and Toutain P.L. Pharmacokinetics of marbofloxacin in horses. Equine Veterinary Journal 34 (2002) 366-372
9. Brown S.A. Fluroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 1-14
10. Burrows G.E. Effects of experimentally induced Mannheimia haemolytica pneumonia on the pharmacokinetics of erythromycin in the calf. American Journal of Veterinary Research 46 (1985) 798-803
11. Dassanayake L., and White G. Administration of a bolus formulation of gaquloprim and sulphadimidine to calves: plasma concentration-time profiles and efficacy in suppressing experimental pneumonic pasteurellosis. Veterinary Microbiology 38 (1994) 255-262
12. De Lucas J.J., Rodriguez C., Waxman S., Gonzalez F., Uriarte I., and San Andres M.I. Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches. Veterinary Journal 170 (2005) 364-368
13. Drugeon, H., Thomas, V., Gaillandeau, L., Thomas, E., 1997. Antibacterial activity of marbofloxacin against bovine respiratory isolates. In: Proceedings of the 7th EAVPT International Congress, Madrid, Spain. Journal of Veterinary Pharmacology and Therapeutics, Suppl. 1, 138-139.
14. Forrest A., Nix D.E., Ballow C.H., Goss T.F., Birmingham C., and Schentag J.J. Pharmcodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37 (1993) 1071-1081
15. Gibaldi M., and Perrier D. Pharmacokinetics. second ed. (1982), Marcel Dekker, New York pp. 409-424
16. Grandemange P.E., Mathevet E., Charrier J., and Davot L. Use of marbofloxacin to treat K99 Escherichia coli gastroenteritis in newborn calves. Irish Veterinary Journal 55 (2002) 180-189
17. Hasegawa T., Takagi K., and Kitaichi K. Effects of bacterial endotoxin on drug pharmacokinetics. Nagoya Journal of Medical Science 62 (1999) 11-28
18. Heinen E. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics 25 (2002) 1-5
19. Highland, R., Copeland, D., Davidson, J., Terhune, T., Lechtenberg, K., Johnson, E., Miles, D., Apley, M., Wray, M., 1994. Dose determination and clinical evaluation of the efficacy of enrofloxacin injectable solution in the treatment of bovine respiratory disease. In: Proceedings of the 18th World Buiatrics Congress, pp. 627-630.
20. Hodgson J.C., Moon G.M., Quirie M., and Donachie W. Association of LPS chemotype of Mannheimia (Pasteurella) haemolytica A1 with disease virulence in a model of ovine pneumonic pasteurellosis. Journal of Endotoxin Research 9 (2003) 25-32
21. Jernigan A.D., Hatch R.C., Wilson R.C., Brown J., and Crowell W.A. Pathologic changes and tissue gentamicin concentrations after intravenous administration in clinically normal and endotoxemic cats. American Journal of Veterinary Research 49 (1988) 613-617
22. Jha K., Roy B.K., and Singh R.C. The effect of induced fever on the biokinetics of norfloxacin and its interaction with probencid in goats. Journal of Veterinary Pharmacology and Therapeutics 20 (1996) 473-479
23. MAFF, 1984. Manual of Veterinary Investigation Laboratory Technique, third ed., vol. 1 Her Majesty's Stationary Office, London, p. 46.
24. McKellar S.F., Sanchez B., and Jones D.G. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 503-514
25. Meunier D., Acar J.F., Martel J.L., Kroemer S., and Vallé M. Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries. International Journal of Antimicrobial Agents 24 (2004) 268-278
26. NCCLS, 1993. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically, third ed. Approved standard, M7-A3.
27. Olchowy T.W., TerHune T.N., and Herrick R.L. Efficacy of difloxacin in calves experimentally infected with Mannheimia haemolytica. American Journal of Veterinary Research 61 (2000) 710-713
28. Ole-Mapenay I.M., Mttema E.S., and Mattho T.E. Aspects of the pharmacokinetics of doxycycline given to healthy and pneumonic East African Dwarf goats by intramuscular injection. Veterinary Research Communications 21 (1997) 453-462
29. Petracca K., Riond J.L., Graser T., and Wanner M. Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows. Journal of Veterinary Medicine A 40 (1993) 73-79
30. Rao G.S., Ramesh S., Ahmad A.H., Tripathi H.C., Sharma L.D., and Malik J.K. Effects of endotoxin-induced fever and probencid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats. Journal of Veterinary Pharmacology and Therapeutics 23 (2000) 365-372
31. Salam Abdullah A., and Baggot J.D. Influence of Escherichia coli endotoxin-induced fever on pharmacokinetics of imidocarb in dogs and goats. American Journal of Veterinary Research 45 (1984) 2645-2648
32. Schneider M., Thomas V., Boisrame B., and Deleforge J. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 56-61
33. Shem-Tov M., Ziv G., Glickman A., and Saran A. Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. Journal of Veterinary Medicine A 44 (1997) 511-519
34. Singhvi S.M., Heald A.F., Gadebusch H.H., Resnick M.E., Ditazio L.T., and Leitz M.A. Human serum protein binding of cephalosporin antibiotics in vitro. Journal of Laboratory and Clinical Medicine 89 (1977) 414-420
35. Spurlock H., Laundry S.L., Sams S., McGurik S., and Muir W.W. Effect of endotoxin administration on body fluid compartments in the horse. American Journal of Veterinary Research 46 (1985) 1117-1120
36. Sullivan M.C., Cooper B.W., Nightingale C.H., Quintiliani R., and Lawlor M.T. Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrobial Agents and Chemotherapy 37 (1993) 234-239
37. Thomas V., Deleforge J., and Boisrame B. Pharmacokinetics of marbofloxacin in pre-ruminant and ruminant cattle. Proceedings of the 6th International Congress of the European Association of Veterinary Pharmacology and Toxicology (EAVPT), Edinburgh, UK (1994), Blackwell Scientific Publication, Oxford, UK 60-61
38. Thomas V., Deleforge J., Boisrame B., and Espinasse J. Pharmacokinetics of marbofloxacin in healthy and sick pre-ruminant cattle. Proceedings of the 6th International Congress of the European Association of Veterinary Pharmacology and Toxicology (EAVPT), Edinburgh, UK (1994), Blackwell Scientific Publication, Oxford, UK 61
39. Thomas E., Caldow G.L., Borell D., and Davot J.L. A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics 24 (2001) 353-358
40. Vancustem P., Babish J., and Schwark S. The fluoroquinolones antimicrobials structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Veterinary 80 (1990) 173-186
41. van-Miert A.S.J.P.A.M. Influence of febrile disease on the pharmacokinetics of veterinary drugs. Annales de Recherche Veterinaire 21 (1990) 115-285
42. Waxman S., Garcia-Montijano M., Sanchez M., Ballesteros C., San Andres M.I., Gonzalez F., and Rodriguez C. Pharmacokinetic behavior of marbofloxacin after oral administration in Buteo buteo. Journal of Veterinary Pharmacology and Therapeutics 23 (2000) B51
43. Waxman S., Rodriguez C., Gonzalez F., DeVicente M.L., San Andres M.I., and San Andres M.D. Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats. Journal of Veterinary Pharmacology and Therapeutics 24 (2001) 370-375
44. Waxman S., San Andres M.D., Gonzalez F., De Lucas J.J., San Andres M.I., and Rodriguez C. Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behaviour of marbofloxacin after intravenous administration in goats. Journal of Veterinary Pharmacology and Therapeutics 26 (2003) 65-69